Total Payments
$16,106
2024 Payments
$1,350
Companies
39
Transactions
665
Medicare Patients
8,760
Medicare Billing
$617,235
Payment Breakdown by Category
Food & Beverage$11,156 (69.3%)
Consulting$4,921 (30.6%)
Education$28.70 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,156 | 660 | 69.3% |
| Consulting Fee | $4,921 | 3 | 30.6% |
| Education | $28.70 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,769 | 52 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,413 | 81 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,274 | 84 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,063 | 62 | $0 (2024) |
| Amgen Inc. | $936.13 | 56 | $0 (2024) |
| PFIZER INC. | $842.90 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $614.81 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $601.50 | 38 | $0 (2024) |
| Boston Scientific Corporation | $542.49 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $435.58 | 31 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,350 | 67 | Janssen Pharmaceuticals, Inc ($279.28) |
| 2023 | $1,462 | 83 | PFIZER INC. ($235.56) |
| 2022 | $1,310 | 81 | Novartis Pharmaceuticals Corporation ($247.72) |
| 2021 | $6,283 | 92 | E.R. Squibb & Sons, L.L.C. ($5,014) |
| 2020 | $577.93 | 34 | Janssen Pharmaceuticals, Inc ($84.12) |
| 2019 | $1,751 | 102 | SANOFI-AVENTIS U.S. LLC ($252.92) |
| 2018 | $1,727 | 110 | SANOFI-AVENTIS U.S. LLC ($301.97) |
| 2017 | $1,645 | 96 | SANOFI-AVENTIS U.S. LLC ($205.61) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Not Applicable | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/17/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/28/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,172 | 3,069 | $455,873 | $160,714 |
| 2022 | 14 | 2,160 | 2,938 | $468,476 | $154,153 |
| 2021 | 17 | 2,316 | 3,147 | $432,378 | $165,200 |
| 2020 | 22 | 2,112 | 2,572 | $389,766 | $137,167 |
Total Patients
8,760
Total Services
11,726
Medicare Billing
$617,235
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 463 | 797 | $162,285 | $77,482 | 47.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 135 | 141 | $64,155 | $20,870 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 103 | $29,870 | $13,961 | 46.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 541 | 953 | $76,240 | $10,651 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $17,920 | $8,593 | 48.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 119 | 122 | $17,780 | $6,649 | 37.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 97 | $14,550 | $6,252 | 43.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 368 | 436 | $25,288 | $2,860 | 11.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 42 | 42 | $7,051 | $2,411 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $4,615 | $2,363 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 35 | $4,670 | $2,154 | 46.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 12 | 12 | $4,800 | $1,996 | 41.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,575 | $1,389 | 38.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 51 | 54 | $3,510 | $997.07 | 28.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 42 | 42 | $6,216 | $673.52 | 10.8% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 49 | 52 | $2,184 | $515.07 | 23.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 42 | 42 | $8,484 | $452.40 | 5.3% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 47 | 47 | $2,679 | $443.21 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 424 | 699 | $163,680 | $67,121 | 41.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 147 | 162 | $73,710 | $26,095 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 102 | $33,780 | $14,814 | 43.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 514 | 865 | $69,200 | $9,672 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $20,490 | $9,092 | 44.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 122 | 122 | $17,780 | $6,945 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 98 | $14,700 | $5,786 | 39.4% |
About Dr. Kevin Lax, MD
Dr. Kevin Lax, MD is a Cardiovascular Disease healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063414514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Lax, MD has received a total of $16,106 in payments from pharmaceutical and medical device companies, with $1,350 received in 2024. These payments were reported across 665 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($11,156).
As a Medicare-enrolled provider, Lax has provided services to 8,760 Medicare beneficiaries, totaling 11,726 services with total Medicare billing of $617,235. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Meadowbrook, PA
- Active Since 08/15/2005
- Last Updated 12/21/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1063414514
Products in Payments
- ELIQUIS (Drug) $1,416
- XARELTO (Drug) $1,400
- ENTRESTO (Drug) $951.39
- MULTAQ (Drug) $671.82
- VERQUVO (Drug) $614.81
- Repatha (Biological) $582.57
- Vascepa (Drug) $435.58
- PRALUENT (Drug) $391.38
- Corlanor (Drug) $353.56
- LEQVIO (Drug) $322.43
- BRILINTA (Drug) $277.07
- FARXIGA (Drug) $247.63
- LEXISCAN (Drug) $247.42
- PRALUENT ALIROCUMAB INJECTION (Biological) $234.00
- WATCHMAN (Device) $205.96
- WATCHMAN FLX (Device) $168.68
- JARDIANCE (Drug) $165.82
- Veltassa (Drug) $120.57
- LifeVest (Device) $112.97
- CAMZYOS (Drug) $112.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Meadowbrook
Thomas Santilli, Md, MD
Cardiovascular Disease — Payments: $25,074
Cardiovascular Disease $25,074
Andrew Mustin, Md, MD
Cardiovascular Disease — Payments: $12,375
Cardiovascular Disease $12,375
John Green
Cardiovascular Disease — Payments: $11,265
Cardiovascular Disease $11,265
Peter Shaftel, Md, MD
Cardiovascular Disease — Payments: $10,251
Cardiovascular Disease $10,251
Dr. George Moutsatsos, M.d, M.D
Cardiovascular Disease — Payments: $853.74
Cardiovascular Disease $853.74
Dr. Bradford Lin, M.d, M.D
Cardiovascular Disease — Payments: $31.30
Cardiovascular Disease $31.30